PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE - DIAMEDICA THERAPEUTICS INC ownership

DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 1 filers reported holding DIAMEDICA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE ownership history of DIAMEDICA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,212,600
-13.6%
470,000
+44.6%
3.97%
+38.3%
Q2 2023$1,404,000325,0002.87%
Other shareholders
DIAMEDICA THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Manatuck Hill Partners, LLC 267,300$1,326,0000.62%
Worth Venture Partners, LLC 132,514$657,0000.36%
WEXFORD CAPITAL LP 400,000$1,984,0000.23%
Eidelman Virant Capital 35,000$173,0000.09%
Granite Point Capital Management, L.P. 229,970$1,141,0000.08%
Patriot Financial Group Insurance Agency, LLC 2,000$10,0000.00%
GABLES CAPITAL MANAGEMENT INC. 125$1,0000.00%
FNY Investment Advisers, LLC 521$2,0000.00%
MILLENNIUM MANAGEMENT LLC 99,340$493,0000.00%
TORONTO DOMINION BANK 48$00.00%
View complete list of DIAMEDICA THERAPEUTICS INC shareholders